Cargando…
Challenge in Predicting Persistence to P2Y12 Inhibitors: A Perspective From the ARTEMIS Trial
BACKGROUND: Premature discontinuation of P2Y12 inhibitor therapy has been associated with adverse cardiac events, which might be preventable by improving medication persistence. Current risk models have limited ability to predict patients at risk of P2Y12 inhibitor nonpersistence. METHODS AND RESULT...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10356056/ https://www.ncbi.nlm.nih.gov/pubmed/37301758 http://dx.doi.org/10.1161/JAHA.122.029063 |